AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026Net selling: insiders sold $1M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net buying of $2K to $30K in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$1M netNet selling
- CongressSTOCK Act, last 180 days
- +$2K to +$30K netNet buying
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 3 cutMore cutting
- Federal contractsUSAspending.gov, last 12 months
- 10+ awardsAwards on record
Market overview
Fundamentals Oct 5- Open
- $89.83
- 52-wk high
- $107.62
- High
- $91.02
- 52-wk low
- $72.76
- Low
- $88.67
- Prev close
- $89.37
- Mkt cap
- $7.45B
- P/E
- 32.5x
- Volume
- 834.4K
- Fwd P/E
- 19.7x
- Beta
- 0.23
- P/S
- 5.5x
- P/B
- 3.8x
- Profit margin
- +17.4%
- Op margin
- +28.4%
- ROE
- +11.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about HQY filings
Are insiders buying or selling HealthEquity Inc (HQY) stock?
Net selling: insiders sold $1M and bought $0 of HQY stock on the open market in the 90 days to Oct 5, 2026, according to SEC Form 4 filings. $1M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Dillon, Adrian T (Director), who sold $798K. The latest filing was on Aug 27, 2026.
Which members of Congress have traded HQY recently?
Rep. Gilbert Cisneros (D) bought $1K to $15K on Jul 10, 2026, disclosed 56 days later. Rep. Gilbert Cisneros (D) bought $1K to $15K on Jun 30, 2026, disclosed 2 days later. In total, 1 member disclosed 2 HQY trades with trade dates in the last 180 days, filed a median 29 days after trading.
How current is this HQY smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- CI
Citadel
$39.2M
added
Sells/Trims (2)
- BA
Balyasny
$69.8M
sold
- MI
Millennium
$45.0M
trimmed
What insiders are doing
What Congress is doing
How top traders are positioned
No tracked top-trader positions in HQY right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 5.1% above what analysts expected.
Last report
Aug 27, 2026
Period ending
Jul 31, 2026
Earnings per share
$0.99 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jul 31, 2026 | Aug 27, 2026 | $1.04 / $0.99Alpha Vantage | +5.05% beat | Unavailable | Unavailable |
| Apr 30, 2026 | May 28, 2026 | $1.07 / $0.94Alpha Vantage | +13.83% beat | Unavailable | Unavailable |
| Jan 31, 2026 | Mar 17, 2026 | $0.95 / $0.90Alpha Vantage | +5.77% beat | Unavailable | Unavailable |
| Oct 31, 2025 | Dec 3, 2025 | $1.01 / $0.91Alpha Vantage | +10.99% beat | Unavailable | Unavailable |
| Jul 31, 2025 | Sep 2, 2025 | $1.08 / $0.92Alpha Vantage | +17.39% beat | Unavailable | Unavailable |
| Apr 30, 2025 | Jun 3, 2025 | $0.97 / $0.81Alpha Vantage | +19.75% beat | Unavailable | Unavailable |
| Jan 31, 2025 | Mar 18, 2025 | $0.69 / $0.72Alpha Vantage | -4.17% miss | Unavailable | Unavailable |
| Oct 31, 2024 | Dec 9, 2024 | $0.78 / $0.72Alpha Vantage | +8.33% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
What the street expects next
Financials
What it sold, what it cost, what was left.
| USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $322.2M | $334.6M | $354.6M | $350.7M |
| Cost of what it sold | $121.1M | $25.4M | $98.3M | $92.8M |
| Gross profit | $201.1M | $309.2M | $256.3M | $258.0M |
| What it spent | ||||
| Research and development | $65.9M | $70.4M | $67.8M | $73.9M |
| Sales and admin | $30.9M | $146.5M | $31.1M | $34.9M |
| Other operating costs | $24.4M | $24.9M | $54.5M | $50.5M |
| Total operating expenses | $121.2M | $241.8M | $153.4M | $159.3M |
| What was left | ||||
| Operating profit | $79.9M | $67.4M | $103.0M | $98.7M |
| Interest on debt | $14.0M | $13.3M | $12.6M | $12.6M |
| Profit before tax | $67.5M | $60.9M | $92.4M | $87.9M |
| Tax | $15.8M | $11.2M | $23.0M | $22.2M |
| Net profit | $51.7M | $49.7M | $69.4M | $65.6M |
| EBITDA | $120.4M | $100.7M | $106.0M | $142.4M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
HealthEquity stock adds a director after Q2 revenue reaches USD 350.73 million
NeutralOct 4HealthEquity Appoints Moody’s CFO Noémie Heuland to Board of Directors
BullishSep 30A director reports 2,033 shares at HealthEquity (HQY), with delivery upon June 2027 vesting.
NeutralSep 30HealthEquity Appoints Moody’s CFO Noémie Heul
NeutralSep 30HealthEquity adds Moody’s CFO to board of directors By Investing.com
Leans bullishSep 30HealthEquity adds Moody’s CFO to board of directors
Leans bullishSep 30Noémie Heuland joins HealthEquity board as CFO of Moody’s, to serve on Audit & Cybersecurity committees
Leans bullishSep 30HealthEquity adds Moody’s CFO to board of directors By Investing.com
Leans bullishSep 30
Macro
24 macro signals shaping HQY right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results